دورية أكاديمية
Chronic Morphine Leaves a Durable Fingerprint on Whole-Brain Functional Connectivity.
العنوان: | Chronic Morphine Leaves a Durable Fingerprint on Whole-Brain Functional Connectivity. |
---|---|
المؤلفون: | Sourty M; University of Strasbourg, French Institute of Health and Medical Research UMR-S 1329, Strasbourg Translational Neuroscience and Psychiatry, Centre de Recherche en Biomedicine de Strasbourg, Strasbourg, France; iCube, University of Strasbourg, National Centre for Scientific Research, Strasbourg, France., Champagnol-Di Liberti C; University of Strasbourg, French Institute of Health and Medical Research UMR-S 1329, Strasbourg Translational Neuroscience and Psychiatry, Centre de Recherche en Biomedicine de Strasbourg, Strasbourg, France., Nasseef MT; Douglas Research Center, Department of Psychiatry, McGill University, Montréal, Quebec, Canada; Department of Mathematics, College of Science and Humanity Studies, Prince Sattam Bin Abdulaziz University, Al-Kharj, Saudi Arabia., Welsch L; University of Strasbourg, French Institute of Health and Medical Research UMR-S 1329, Strasbourg Translational Neuroscience and Psychiatry, Centre de Recherche en Biomedicine de Strasbourg, Strasbourg, France; Douglas Research Center, Department of Psychiatry, McGill University, Montréal, Quebec, Canada., Noblet V; iCube, University of Strasbourg, National Centre for Scientific Research, Strasbourg, France., Darcq E; University of Strasbourg, French Institute of Health and Medical Research UMR-S 1329, Strasbourg Translational Neuroscience and Psychiatry, Centre de Recherche en Biomedicine de Strasbourg, Strasbourg, France; Douglas Research Center, Department of Psychiatry, McGill University, Montréal, Quebec, Canada., Kieffer BL; University of Strasbourg, French Institute of Health and Medical Research UMR-S 1329, Strasbourg Translational Neuroscience and Psychiatry, Centre de Recherche en Biomedicine de Strasbourg, Strasbourg, France; Douglas Research Center, Department of Psychiatry, McGill University, Montréal, Quebec, Canada. Electronic address: brigitte.kieffer@unistra.fr. |
المصدر: | Biological psychiatry [Biol Psychiatry] 2023 Dec 15. Date of Electronic Publication: 2023 Dec 15. |
Publication Model: | Ahead of Print |
نوع المنشور: | Journal Article |
اللغة: | English |
بيانات الدورية: | Publisher: Elsevier Country of Publication: United States NLM ID: 0213264 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2402 (Electronic) Linking ISSN: 00063223 NLM ISO Abbreviation: Biol Psychiatry Subsets: MEDLINE |
أسماء مطبوعة: | Publication: New York, NY : Elsevier Original Publication: New York, Plenum Pub. Corp. |
مستخلص: | Background: Opioid use disorder is a chronic relapsing disorder. The brain adapts to opioids that are taken for pain treatment or recreational use so that abstinence becomes a true challenge for individuals with opioid use disorder. Studying brain dysfunction at this stage is difficult, and human neuroimaging has provided highly heterogeneous information. Methods: Here, we took advantage of an established mouse model of morphine abstinence together with functional magnetic resonance imaging to investigate whole-brain functional connectivity (FC) first at rest and then in response to an acute morphine challenge during image acquisition. Results: Hierarchical clustering of seed pair correlation coefficients showed modified FC in abstinent animals, brainwide and regardless of the condition. Seed-to-voxel analysis and random forest classification, performed on data at rest, indicated that the retrosplenial cortex (a core component of the default mode network) and the amygdala (a major aversion center) are the best markers of abstinence, thus validating the translatability of the study. Seed pair network clustering confirmed disruption of a retrosplenial cortex-centered network, reflecting major reorganization of brain FC. The latter analysis also identified a persistent but unreported morphine signature in abstinent mice at rest, which involves cortical and midbrain components and characterizes the enduring morphine footprint. Finally, dynamic FC analysis revealed that the intrascanner acute morphine challenge modified FC faster and more broadly in abstinent animals, demonstrating brainwide adaptations of FC reactivity to an acute opioid challenge. Conclusions: This study used a unique experimental design to demonstrate that a prior history of chronic opioid exposure leaves a durable pharmacological signature on brain communication, with implications for pain management and recovery from opioid use disorder. (Copyright © 2023 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.) |
References: | ACS Pharmacol Transl Sci. 2019 Jun 28;2(4):264-274. (PMID: 32259060) Neuroimage. 2016 Feb 15;127:496-509. (PMID: 26706448) Addict Neurosci. 2022 Mar;1:. (PMID: 37323812) Brain Struct Funct. 2021 Apr;226(3):647-669. (PMID: 33635426) Proc Natl Acad Sci U S A. 2016 Oct 11;113(41):11603-11608. (PMID: 27671662) Neurosci Biobehav Rev. 2009 Mar;33(3):279-96. (PMID: 18824195) Biol Psychiatry. 2011 Feb 1;69(3):236-44. (PMID: 20947067) J Pharmacol Exp Ther. 2013 Apr;345(1):41-51. (PMID: 23370795) Addict Biol. 2017 Jul;22(4):1010-1021. (PMID: 27001273) Transl Psychiatry. 2022 Feb 26;12(1):81. (PMID: 35217657) Behav Brain Res. 2011 Jan 20;216(2):639-646. (PMID: 20851718) Biol Psychiatry. 2017 May 1;81(9):778-788. (PMID: 28185645) Front Hum Neurosci. 2017 Apr 06;11:169. (PMID: 28428748) Biol Psychiatry. 2023 Mar 15;93(6):489-501. (PMID: 36435669) Pharmacol Rev. 2021 Jul;73(3):1050-1083. (PMID: 34257149) Nat Neurosci. 2023 Feb;26(2):316-325. (PMID: 36536243) Biol Psychiatry. 2020 Jan 1;87(1):54-63. (PMID: 31521334) J Neurosci Res. 2015 Nov;93(11):1693-702. (PMID: 26280556) J Addict Dis. 2017 Apr-Jun;36(2):105-116. (PMID: 28095255) Biol Psychiatry. 2024 Feb 1;95(3):266-274. (PMID: 37517704) Neuroscience. 2018 May 15;378:113-145. (PMID: 27884551) Neuroimage. 2014 Aug 1;96:203-15. (PMID: 24718287) Cell Rep. 2023 Feb 28;42(2):112089. (PMID: 36796365) Nat Rev Neurosci. 2020 Nov;21(11):625-643. (PMID: 33024318) Nat Rev Neurosci. 2018 Aug;19(8):499-514. (PMID: 29934561) Curr Opin Neurol. 2008 Aug;21(4):424-30. (PMID: 18607202) Brain Res. 2011 Jul 21;1402:46-53. (PMID: 21669407) Curr Opin Pharmacol. 2013 Oct;13(5):813-20. (PMID: 23856429) Mol Psychiatry. 2022 Feb;27(2):865-872. (PMID: 34650202) Neuroimage. 2010 Jan 1;49(1):738-44. (PMID: 19703568) Biol Psychiatry. 2023 Dec 1;94(11):852-862. (PMID: 37393045) Neuropsychopharmacology. 2019 Feb;44(3):465-477. (PMID: 30293087) Proc Natl Acad Sci U S A. 2021 Oct 26;118(43):. (PMID: 34675078) Front Psychiatry. 2019 Mar 07;10:117. (PMID: 30899231) Neuropsychopharmacology. 2014 Oct;39(11):2694-705. (PMID: 24874714) Sci Adv. 2023 Jan 13;9(2):eadd8687. (PMID: 36630511) Addict Biol. 2016 May;21(3):646-56. (PMID: 25727574) Physiol Rev. 2009 Oct;89(4):1379-412. (PMID: 19789384) J Clin Invest. 2019 Mar 26;129(6):2480-2484. (PMID: 30913040) Nat Neurosci. 2023 Apr;26(4):673-681. (PMID: 36973511) Mol Psychiatry. 2021 Jan;26(1):218-233. (PMID: 32020048) Nature. 1996 Oct 31;383(6603):819-23. (PMID: 8893006) PLoS One. 2011 Jan 26;6(1):e16560. (PMID: 21298074) Biol Psychiatry. 2020 Jan 1;87(1):44-53. (PMID: 31400808) N Engl J Med. 2016 Jul 28;375(4):357-68. (PMID: 27464203) Front Syst Neurosci. 2022 Jun 28;16:937126. (PMID: 35837149) Addict Biol. 2022 Sep;27(5):e13209. (PMID: 36001428) Neuropharmacology. 2023 Jul 1;232:109524. (PMID: 37003572) Brain Struct Funct. 2015 Mar;220(2):677-702. (PMID: 24623156) Neuropsychopharmacology. 2019 Jan;44(2):259-273. (PMID: 30283002) Annu Rev Neurosci. 2021 Jul 8;44:173-195. (PMID: 33667115) Pain Manag. 2019 Mar 1;9(2):131-138. (PMID: 30806566) Elife. 2024 Mar 15;13:. (PMID: 38488854) Neuroimage. 2015 Jul 15;115:281-91. (PMID: 25913701) Lancet Psychiatry. 2016 Aug;3(8):760-773. (PMID: 27475769) Nature. 2000 Jun 29;405(6790):1013-4. (PMID: 10890431) Neurosci Lett. 2009 Aug 21;460(1):72-7. (PMID: 19450664) |
معلومات مُعتمدة: | P50 DA005010 United States DA NIDA NIH HHS; R01 DA048796 United States DA NIDA NIH HHS |
فهرسة مساهمة: | Keywords: Amygdala; Default mode network; Functional Magnetic Resonance Imaging; Mouse model; Opioid use disorder |
تواريخ الأحداث: | Date Created: 20231217 Latest Revision: 20240618 |
رمز التحديث: | 20240618 |
مُعرف محوري في PubMed: | PMC11178678 |
DOI: | 10.1016/j.biopsych.2023.12.007 |
PMID: | 38104648 |
قاعدة البيانات: | MEDLINE |
تدمد: | 1873-2402 |
---|---|
DOI: | 10.1016/j.biopsych.2023.12.007 |